Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.3K

GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis

Daniel M Kremer1,2, Barbara S Nelson3, Lin Lin1

  • 1Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.

Nature Communications
|August 12, 2021
PubMed

Insights

Targeting cancer

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Cancer cells rewire metabolism for survival against stressors.
  • A cytosolic aspartate aminotransaminase (GOT1) pathway maintains redox balance in pancreatic cancer.
  • Targeting metabolic adaptations is a key research area.

Purpose of the Study:

  • Identify metabolic vulnerabilities after GOT1 inhibition in pancreatic cancer.
  • Understand redox metabolism regulation.
  • Explore GOT1's role in cancer survival.

Main Methods:

  • Pharmacological inhibition of GOT1.
  • Genetic knockdown of GOT1.
  • Analysis of antioxidant pathways (cysteine, glutathione, lipids).
  • Assessment of ferroptosis induction.
  • Investigation of mitochondrial metabolism and autophagy.

Main Results:

  • GOT1 inhibition reveals vulnerabilities in cysteine, glutathione, and lipid antioxidant pathways.
  • Targeting these pathways induces ferroptosis in GOT1-deficient pancreatic cancer cells.
  • GOT1 inhibition represses mitochondrial metabolism and increases catabolism.
  • This leads to enhanced labile iron availability via autophagy.
  • Increased iron potentiates ferroptosis.

Conclusions:

  • GOT1 inhibition creates dependencies on antioxidant pathways, leading to ferroptosis.
  • GOT1 connects iron regulation and ferroptosis in pancreatic cancer.
  • This study identifies a novel therapeutic vulnerability in pancreatic cancer.

More Related Videos

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

621
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.4K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.1K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K